webui.db — file

Delete row ('af12adcc-95cb-4f54-9b66-58b2ef52409a', '34c7193c-d96f-448e-a617-43d60071f00f', 'Synthetic_Cardiology_Patient_Record.pdf', '{"name": "Synthetic_Cardiology_Patient_Record.pdf", "content_type": "application/pdf", "size": 5724, "data": {"patient_id": "dip_patient_1234"}, "collection_name": "file-af12adcc-95cb-4f54-9b66-58b2ef52409a"}', '1774868055', 'd08e22058336ca20bf5ace7e591ecf031bd6ad6e5e7b24d499e63f39108159a3', '{"status": "completed", "content": "Synthetic Cardiology Patient Record (For RAG\\nTesting)\\nPatient Demographics\\nName:\\nArindam Sen (Synthetic Data)\\nAge:\\n62 years\\nGender:\\nMale\\nDOB:\\n14 March 1963\\nBlood Group:\\nB+\\nMRN:\\nCARD-2026-001-SYN\\nPrimary Physician:\\nDr. R. Mukherjee, MD (Cardiology)\\nChief Complaint\\nProgressive shortness of breath for 3 months, orthopnea, and intermittent chest discomfort on\\nexertion.\\nPast Medical History\\n\\nType 2 Diabetes Mellitus (15 years)\\n\\nHypertension (18 years)\\n\\nChronic Kidney Disease - Stage 2\\n\\nIschemic Heart Disease\\n\\nAnterior Wall Myocardial Infarction (2019)\\n\\nChronic Heart Failure with Reduced Ejection Fraction (HFrEF)\\nCurrent Medications\\n\\nAspirin 75 mg OD\\n\\nClopidogrel 75 mg OD\\n\\nAtorvastatin 40 mg HS\\n\\nMetoprolol Succinate 50 mg OD\\n\\nRamipril 5 mg OD\\n\\nSpironolactone 25 mg OD\\n\\nFurosemide 40 mg OD\\n\\nMetformin 500 mg BD\\n\\nInsulin Glargine 14 units HS\\nAllergies No known drug allergies (NKDA).\\nLaboratory Reports (Last 3 Visits)\\nTest\\nJan 2026\\nFeb 2026\\nMar 2026\\nHbA1c\\n8.4%\\n8.1%\\n7.9%\\nSerum Creatinine\\n1.5 mg/dL\\n1.6 mg/dL\\n1.7 mg/dL\\nBNP\\n480 pg/mL\\n510 pg/mL\\n620 pg/mL\\nLDL\\n112 mg/dL\\n98 mg/dL\\n92 mg/dL\\nPotassium\\n4.6 mmol/L\\n5.1 mmol/L\\n5.4 mmol/L\\nEchocardiography Report (March 2026)\\nLeft ventricular ejection fraction (LVEF): 32%. Global hypokinesia present. Mild mitral regurgitation.\\nLeft atrial enlargement. No pericardial effusion.\\nECG Report\\nSinus rhythm. Q waves in V1-V4 suggestive of old anterior wall MI. Left ventricular hypertrophy\\npattern noted.\\nAdmission Note (SOAP Format)\\nS (Subjective): Patient reports worsening dyspnea (NYHA Class III), mild pedal edema,\\nand reduced exercise tolerance. No syncope.\\nO (Objective): BP 150/92 mmHg, HR 88 bpm, RR 20/min. Bilateral basal crepitations.\\nPitting edema grade 2+. BNP elevated. LVEF 32%.\\nA (Assessment): Acute on chronic systolic heart failure exacerbation.\\nPoor glycemic control. Rising creatinine levels.\\nP (Plan): Increase Furosemide dose temporarily to 80 mg/day. Add SGLT2 inhibitor.\\nStrict salt restriction (<2g/day). Fluid restriction (1.5L/day).\\nCardiology follow-up in 2 weeks. Repeat renal function test in 7 days.\\nDischarge Summary\\nPatient stabilized after IV diuretics. Symptoms improved. Discharged with optimized heart failure\\nregimen. Advised cardiac rehabilitation and lifestyle modification. NOTE: This is entirely synthetic patient data generated for AI/RAG system testing. No real patient\\ninformation is included."}', '1774868055', '/home/sid/xevyo/open-webui-dev/backend/data/uploads/af12adcc-95cb-4f54-9b66-58b2ef52409a_Synthetic_Cardiology_Patient_Record.pdf', 'null') from file